2022
Factors Associated With COVID-19 Death in the United States: Cohort Study
Chen U, Xu H, Krause T, Greenberg R, Dong X, Jiang X. Factors Associated With COVID-19 Death in the United States: Cohort Study. JMIR Public Health And Surveillance 2022, 8: e29343. PMID: 35377319, PMCID: PMC9132142, DOI: 10.2196/29343.Peer-Reviewed Original ResearchMeSH KeywordsAdultBlack or African AmericanCohort StudiesCOVID-19HumansMaleMiddle AgedSARS-CoV-2United StatesWhite PeopleConceptsCOVID-19-related deathsCohort studyPatient characteristicsElectronic health record data setsLarge national cohort studyNational cohort studyChronic respiratory diseasesProportional hazards modelCOVID-19COVID-19 deathsImmunosuppressive conditionsKidney functionMale sexLung cancerCOVID-19 casesRecent diagnosisRisk factorsRespiratory diseaseCardiac diseaseOrgan transplantsHigh incidenceHazards modelNeurological diseasesOlder ageDisease
2017
Evaluating the role of race and medication in protection of uterine fibroids by type 2 diabetes exposure
Velez Edwards D, Hartmann K, Wellons M, Shah A, Xu H, Edwards T. Evaluating the role of race and medication in protection of uterine fibroids by type 2 diabetes exposure. BMC Women's Health 2017, 17: 28. PMID: 28399866, PMCID: PMC5387248, DOI: 10.1186/s12905-017-0386-y.Peer-Reviewed Original ResearchConceptsT2D medicationsUF riskAnnual healthcare costsElectronic medical record algorithmCase-control studyLarge clinical populationFurther mechanistic researchBackgroundUterine fibroidsT2D diagnosisDiabetes exposureMedication typeDiabetes presenceInsulin usersUterine fibroidsInsulin treatmentProtective associationStratified analysisClinical cohortConclusionsThese dataProtective effectLarge cohortCase-control statusHealthcare costsT2DMedications
2012
Predicting warfarin dosage in EuropeanAmericans and AfricanAmericans using DNA samples linked to an electronic health record
Ramirez A, Shi Y, Schildcrout J, Delaney J, Xu H, Oetjens M, Zuvich R, Basford M, Bowton E, Jiang M, Speltz P, Zink R, Cowan J, Pulley J, Ritchie M, Masys D, Roden D, Crawford D, Denny J. Predicting warfarin dosage in EuropeanAmericans and AfricanAmericans using DNA samples linked to an electronic health record. Pharmacogenomics 2012, 13: 407-418. PMID: 22329724, PMCID: PMC3361510, DOI: 10.2217/pgs.11.164.Peer-Reviewed Original ResearchAdultAgedAged, 80 and overAnticoagulantsAryl Hydrocarbon HydroxylasesBlack or African AmericanCalcium-Binding ProteinsCytochrome P-450 CYP2C9Cytochrome P-450 Enzyme SystemCytochrome P450 Family 4Dose-Response Relationship, DrugDrug Administration ScheduleElectronic Health RecordsFemaleHumansMaleMiddle AgedMixed Function OxygenasesPolymorphism, Single NucleotideSubstance-Related DisordersVitamin K Epoxide ReductasesWarfarinWhite People